Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
18 juil. 2018 07h37 HE
|
Precipio, Inc.
Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today...
Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders
15 juin 2018 20h11 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 15, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2018 Annual Meeting of Shareholders, originally...
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
14 juin 2018 12h19 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
Potential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April Results
22 mai 2018 07h37 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 22, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced accelerating sales of its Pathology services in the month of...
Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer
17 mai 2018 07h38 HE
|
Precipio, Inc.
Ultra-sensitive enrichment kit enables development of low cost detection tests, allowing optimized patient treatment NEW HAVEN, Conn., May 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%
14 mai 2018 07h37 HE
|
Precipio, Inc.
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Specialty...
Precipio Completes a $3M Convertible Debt Facility
23 avr. 2018 07h37 HE
|
Precipio, Inc.
Management focuses on growth opportunities NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that it entered into a...
Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell
18 avr. 2018 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 18, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it is in active licensing discussions with several potential partners...
Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call
17 avr. 2018 07h37 HE
|
Precipio, Inc.
Management to provide strategic business update to shareholders NEW HAVEN, Conn., April 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that...
Precipio Launches ICE COLD-PCR™ Research Access Program for Cancer Centers
11 avr. 2018 07h37 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 11, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today the launch of its program to provide complimentary ICE COLD-PCR (ICP)...